New Partnership: Bioz Helps DNA Polymerase Technology to Boost Research Visibility Through Interactive Citation Badges

November 19, 2024 4:00 AM

PALO ALTO, CA / ACCESSWIRE / November 19, 2024 / Bioz, Inc., a driving force in AI-enhanced citation tracking, is pleased to announce a new partnership with DNA Polymerase Technology. By integrating Bioz Badges into their website, researchers can instantly access real-world citation data that highlights a product's proven impact in research, allowing for a seamless, data-driven experience right on the supplier's website.Bioz Original BadgeBioz...

Read more

Kuros Biosciences Expands into Extremities Markets

November 19, 2024 1:20 AM

Commercial HighlightsAppointment of Jantzen Cole as Vice President of Market Development, Extremities, to drive the Company's acceleration beyond the spine marketStrategic expansion opens new addressable market opportunity estimated at $1 billionFormation of a dedicated Surgeon Advisory Board to shape clinical and commercial strategies for MagnetOs TM in extremities marketsZURICH, SWITZERLAND / ACCESSWIRE / November 19, 2024 / Kuros Biosciences...

Read more

MailOrder420 Expands Nationwide: Now Serving All 52 States with Premium Cannabis Products

November 18, 2024 5:10 PM

In a groundbreaking move, MailOrder420, the leading online dispensary, is thrilled to announce its expansion to all 52 states across the USA. This marks a significant milestone in the company's journey to revolutionize the online cannabis industry, offering high-quality products, unparalleled convenience, and a customer-centric approach.Founded with the mission of making premium cannabis products accessible to all, MailOrder420 has rapidly grown...

Read more

Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member

November 18, 2024 5:00 PM

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present the 2024 Q3 Financial Results on a Conference Call on November 26, 2024 at 8:30 am Eastern Time. The Q3 Financials will be filed after closing November 25, 2024.Medicure also announced today that Kimberly...

Read more

Protagonist Announces Positive Topline Results From Phase 3 ICONIC Studies of Icotrokinra (JNJ-2113) in Plaque Psoriasis, a First-in-Class Investigational Targeted Oral Peptide That Selectively Blocks the IL-23 Receptor

November 18, 2024 4:30 PM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced positive topline results from its collaboration with Johnson & Johnson, in ICONIC-LEAD1 and ICONIC-TOTAL2, two pivotal Phase 3 investigational studies of icotrokinra (JNJ-2113, formerly PN-235), the first-in-class targeted oral peptide that selectively blocks the IL-23 receptor, in individuals 12 years of age and older with moderate to severe plaque psoriasis...

Read more

Richard Birkett, MD, Shares His Top 5 Tips to Prepare for an Ironman

November 18, 2024 4:30 PM

BOSTON, MA / ACCESSWIRE / November 18, 2024 / Richard Birkett, MD stands out not only for his medical expertise but also for his athletic prowess. A highly regarded Colon and Rectal Surgeon, Dr. Birkett specializes in advanced minimally invasive robotic and laparoscopic surgeries. He is dedicated to treating a wide range of conditions, including colon and rectal cancer, diverticulitis, gastrointestinal immunologic and benign diseases, and...

Read more

Community Routes: Access to Mental Health Care

November 18, 2024 1:55 PM

US Chamber of Commerce Foundation Citizens Award WinnerNORTHAMPTON, MA / ACCESSWIRE / November 18, 2024 / Teva Pharmaceuticals is proud to share that our Community Routes: Access to Mental Health Care U.S. access program, in partnership with Direct Relief and NAFC (National Association of Free & Charitable Clinics), has been recognized by the U.S. Chamber of Commerce Foundation 25th annual Citizens Award as the 2024 Best Health & Wellness...

Read more

Nine in Ten Integrated Health Systems' Outpatient Services Losing Revenue Due to Flawed RCM Systems: Deficiencies Erode Ancillaries' Financial Performance, Reports Black Book

November 18, 2024 1:15 PM

Integrated Outpatient Facilities Struggle with Inadequate RCM Solutions, Leading to Revenue Loss in Labs, Diagnostic Imaging, Rehabilitation, Home Health and Subacute CareNASHVILLE, TN / ACCESSWIRE / November 18, 2024 / According to the latest findings from Black Book Research, integrated outpatient centers, encompassing a broad range of services such as labs, diagnostic imaging, physical therapy, home health, chemotherapy infusion, and subacute...

Read more

Leadership Evolution Announced by EW Healthcare Partners

November 18, 2024 10:55 AM

Dr. Peti Vainio to become Executive ChairmanDr. Evis Hursever to become CEOScott Barry to become COOMarty Sutter to become Founding PartnerNEW YORK, NY / ACCESSWIRE / November 18, 2024 / EW Healthcare Partners, a trans-Atlantic healthcare private equity firm, today announced that it has appointed Dr. Petri Vainio as Executive Chairman, Dr. Evis Hursever as CEO, Scott Barry as COO, and Marty Sutter as Founding Partner. Petri Vainio, M.D.,...

Read more

Webinar to Address Menopause in the Workplace

November 18, 2024 10:50 AM

Menopause and perimenopause are pivotal life stages that can profoundly impact women's careers, yet workplace policies often fail to address the specific challenges women face in midlife. A new webinar, hosted by Aimed Alliance on HR.com, will explore the results of a recent survey examining employer perspectives on menopause-related symptoms, and how these symptoms impact women's productivity, career progression, and overall workplace...

Read more

EW Healthcare Partners Announces Leadership Evolution

November 18, 2024 10:00 AM

Dr. Petri Vainio to become Executive ChairmanDr. Evis Hursever to become CEOScott Barry to become COOMarty Sutter to become Founding PartnerNEW YORK, NY / ACCESSWIRE / November 18, 2024 / EW Healthcare Partners, a trans-Atlantic healthcare private equity firm, today announced that it has appointed Dr. Petri Vainio as Executive Chairman, Dr. Evis Hursever as CEO, Scott Barry as COO, and Marty Sutter as Founding Partner.Petri Vainio, M.D., Ph.D.,...

Read more

Hypha Laboratories Announces Completion of Phase 1 of Its State-of-the-Art Facility and Arrival of V5 Working MicroPearls(TM) Prototypes

November 18, 2024 9:15 AM

Advancements Enhance Efficacy in Hypha's Revolutionary Home and Commercial Production UnitsLAS VEGAS, NV / ACCESSWIRE / November 18, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce it has completed Phase 1 of construction and design for its Research and Production facility in Las Vegas, Nevada as well as the arrival of its V5...

Read more

Glow Sauna Studios Beems Westward with Multi-Unit Expansion into Kansas City

November 18, 2024 9:00 AM

Glow Sauna Studios, a recognized leader in holistic wellness, is pleased to announce a new multi-unit agreement, in Metro Kansas City, with the first location opening in Overland Park, KS. Danielle, Charles, Jace, and Anakin make up the Osgood family of entrepreneurs. This new venture underscores the family's commitment to bringing impactful, natural health solutions to their community.The wellness market continues to grow as consumers seek...

Read more

CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)

November 18, 2024 8:55 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its abstract has been selected for poster presentation at the 29th Annual Meeting of the Society for Neuro-Oncology being held November 21-24, 2024 in Houston, TX.Details of the presentation are as...

Read more

Epsom Salt Council Sponsors the Arthritis Foundation's North Carolina Jingle Bell Runs to Benefit Critical Research Initiatives

November 18, 2024 8:30 AM

CHARLOTTE, NC / ACCESSWIRE / November 18, 2024 / Epsom Salt Council, an organization dedicated to raising awareness about the health and wellness benefits of Epsom salt (magnesium sulfate), announces its sponsorship of the Arthritis Foundation's 40th annual Jingle Bell Runs in Charlotte and Raleigh this holiday season. The races, taking place on Nov. 23 in Charlotte and Dec. 7 in Raleigh, are annual fundraising initiatives that support critical...

Read more

Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets

November 18, 2024 8:00 AM

CHICAGO, IL / ACCESSWIRE / November 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has adopted a strategy to include Bitcoin and Ethereum as part of...

Read more

Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis

November 18, 2024 8:00 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced the first look at its late-stage RED-C clinical trial program which will be presented at the American Association for the Study of Liver Disease (AASLD), The Liver Meeting® in San Diego, CA. This clinical program was designed to assess the efficacy of a next generation therapeutic, a soluble solid dispersion...

Read more

PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS

November 18, 2024 8:00 AM

LAVAL, QC / ACCESSWIRE / November 18, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE/TSX:BHC), today announced that PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) gel 1.2% w/w, 0.15% w/w and 3.1% w/w, a new triple-combination topical prescription treatment for acne vulgaris in patients 12 years of age and older,1 has received positive reimbursement recommendations from Canada's Drug Agency...

Read more

NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders

November 18, 2024 7:30 AM

NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, provided insights today into the preclinical program evaluating its dual orexin receptor agonist (DOXA) platform. AEX-41 and AEX-2, two first-in-class non-sulfonamide DOXAs, are designed to...

Read more

Interactive Strength Inc. (Nasdaq:TRNR) Expands CLMBR’s Presence with Military and College Accounts by Exhibiting at the Athletic Business Show on November 19-22

November 18, 2024 7:00 AM

Interactive Strength Inc. (NASDDAQ:TRNR) ("TRNR" or "the Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that the Company will be exhibiting CLMBR to focus on Military and College/High School accounts at the Athletic Business Show on November 19-22 in New Orleans, Louisiana.Trent Ward, Co-Founder and CEO of TRNR, said: "The Athletic Business Show is the key annual event for buyers from...

Read more